, Singapore
105 views
/JW Ju from Unsplash

MSIG Singapore to maintain footing from parent support: S&P Global

S&P Global Ratings said the insurer will remain highly strategic.

MSIG Insurance Singapore is forecasted to have a stable outlook, with expected continuous support for the next two years from its parent, Mitsui Sumitomo Insurance (MSI).

“We also continue to view MSIG Singapore as a highly strategic subsidiary of MS&AD Insurance Group Holdings Inc., resulting in likely group support,” said S&P Global Ratings in a press release.

The insurer’s financial strength rating reflects the support MSI, which provides the company a form of a guarantee on its insurance policy obligations. The ratings agency therefore equalises its rating on MSIG Singapore with that on MSI.

ALSO READ: MSIG Asia’s CEO shares approach to risk management evolution

MSIG Singapore was also perceived to underpin the group’s regional growth efforts and has been consistent in delivering P&C returns in Singapore.

More traits that seem to benefit MS&AD Insurance Group are MSIG Singapore’s contributions and sustained focus on local business.

Thus, the rating agency expects the insurer to keep its position as one of the top-performing P&C insurers by gross written premiums in the country.

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.